MedPath

KIMMTRAK

KIMMTRAK

Approved
DIN Number

02527588

Drug Class

Human

Market Date

Aug 23, 2022

Company
HC

IMMUNOCORE IRELAND LIMITED

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02527588
AIG Number0163721001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D ,  Prescription
A
ATC Code
L01XX75 TEBENTAFUSP
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous
AHFS Classification10:00.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

TEBENTAFUSPActive
Strength: 100 MCG / 0.5 ML
Monograph: TEBENTAFUSP

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.